A dose-response evaluation of androgens in the treatment of metastatic breast cancer.
D000732:Androstanols / Q000008:administration & dosage / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D009277:Nandrolone / Q000008:administration & dosage / Q000627:therapeutic use*; D009362:Neoplasm Metastasis; D012075:Remission, Spontaneous; D013997:Time Factors
D000732:Androstanols; D000970:Antineoplastic Agents; D009277:Nandrolone